Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by palinc2000on Dec 16, 2021 5:33pm
205 Views
Post# 34238671

RE:RE:RE:New Form 6 K just filed

RE:RE:RE:New Form 6 K just filedIHowever this would seem to indicate that the intent under the original ATM agreement was to draw under the ATM prior to today as is usual under ATM agreement,...short term instrument.
So as we all know the SP did not perform well and probably did not perform according to the company s expectations
palinc2000 wrote:
The original agreement had an automatic termination date upon the occurence of certain events see below......So you are right I think that it is tied to the original Form 10 filing ......But the agreement would have elapsed had they not renewed the F 10 this week 
   
  1. This Agreement shall terminate automatically upon any of the following occurrences: (1) the aggregate gross proceeds of Placement Shares sold under this Agreement has reached the maximum of U.S. $50,000,000 or (2) the effectiveness of the U.S. Prospectus and the Canadian Prospectus has lapsed, being the date falling on the 25th month of the date of the Canadian Base Prospectus, provided, however, that if the maximum amount of gross proceeds of Placement Shares to be sold hereunder has not been reached and the Company has filed with the AMF a new Canadian preliminary short form base shelf prospectus, together with a new prospectus supplement thereto relating to the offering of Placement Shares contemplated hereunder, and with the Commission a new registration statement on Form F-10 and the new Canadian prospectus supplement thereto relating to the offering of Placement Shares contemplated hereunder, with the effect of renewing such documents, the parties may agree in writing that this Agreement will continue to be effective and govern the offering of Placement Shares up to the amount of gross proceeds then remaining. In such event, all references in this Agreement to the “Canadian Base Prospectus”, “Canadian Supplement”, “U.S. Base Prospectus” and “U.S. Supplement” shall be references respectively to such new Canadian short form base shelf prospectus, Canadian prospectus supplement thereto relating to the offering of the Placement Shares contemplated hereunder, U.S. registration statement on Form F- 10 and prospectus supplement thereto relating to the offering of the Placement Shares contemplated hereunder.

            


SPCEO1 wrote: I don't have time to give it a good look but we did have something regarding the original terms and I think this is not anything particularly noteworthy. My guess is it is tied to the filing of the prospectus and just a legal thing that had to be completed to make sure everything remained in order. But I do not remember there being a deadline for the ATM and can't imagine it would ahve been that short a time period in any event.

palinc2000 wrote: Extending the ATM sales agreement with Cantor 
I dont recall if we had access to the original sales agreement but it appears that the intended maximum date to sell the sharesunder the ATM has expired,,,Spceo is that your take?

 




<< Previous
Bullboard Posts
Next >>